Guillermo Garcia-Manero, MD¹, Aaron D Goldberg, MD, PhD², Eric S. Winer, MD³, Jessica K. Altman, MD⁴, Amir T. Fathi, MD⁵, Olatoyosi Odenike, MD⁶, Gail J. Roboz, MD⁷, Phillip Gallacher^8*, Anders Wennborg, MD, PhD^8*, Denice Kaylor Hickman, BSN, RN^8*, Eyal C. Attar, MD⁸ and David A. Sallman, MD⁹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
⁷Division of Hematology Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁸Aprea Therapeutics, Boston, MA
⁹Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

Sonja Loges, MD, PhD^1*, Michael Heuser, MD², Jörg Chromik, MD^3*, Grerk Sutamtewagul, MD⁴, Silke Kapp-Schwoerer, MD^5*, Monica Crugnola, MD^6*, Nicola Di Renzo, MD^7*, Roberto M. Lemoli, MD⁸, Daniele Giovanni Mattei, MD⁹, Isabel Ben Batalla, PhD^10,11*, Monica Hellesøy, MS, PhD^12*, Jonas Waizenegger, M.D.^11*, Lisa-Marie Rieckmann, M.Sc^13*, Melanie Janning, MD^11,14*, Charles D. Imbusch, PhD^15*, Niklas Beumer, M.Sc^16*, Austin Rayford, M.Sc^17*, Jaya Nautiyal, PhD^18*, Tzivia Berkman-Gottlieb, MSc^19*, David Micklem, PhD^20*, Hani Gabra, MD, PhD, FRCPE, FRCP^18*, Claudia Gorcea-Carson, MD^21*, James B. Lorens, PhD^22*, Walter Fiedler, MD²³, Yesid Alvarado, MD²⁴ and Bjorn T. Gjertsen, MD, PhD²⁵

¹Universitätsklinikum Mannheim, Mannheim, Germany
²Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
³Medical Clinic II, Hematology, Hemostaseology, Medical Oncology, Rheumatology, Infectious Disease, University Hospital Frankfurt, Frankfurt, Germany
⁴Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA
⁵Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
⁶Hematology and BMT Center, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
⁷Department of Hematology and Stem Cell Transplant, Presidio Ospedaliero Vito Fazzi, Lecce, Italy
⁸University of Genoa, Genoa, Italy
⁹Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
¹⁰German Cancer Research Center (DKFZ), University of Mannheim, Mannheim, Germany
¹¹Department of Personalised Oncology, University Medical Center Mannheim, Mannheim, Germany
¹²Department of Internal Medicine, Hematology section, Haukeland University Hospital, Bergen, Norway
¹³German Cancer Research Center (DKFZ), Heidelberg, Germany
¹⁴German Cancer Research Center (DKFZ), Heidelberg, Heidelberg, Germany
¹⁵Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
¹⁶Department of Personalised Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
¹⁷BerGenBio ASA, Bergen, Norway
¹⁸Translational Biomarkers, BerGenBio ASA, Oxford, United Kingdom
¹⁹Data Analysis, BerGenBio ASA, Oxford, United Kingdom
²⁰Translational Biomarkers, BerGenBio ASA, Bergen, Norway
²¹BerGenBio ASA, Oxford, United Kingdom
²²Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway
²³Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany
²⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁵Haukeland University Hospital, Bergen, Norway

Maro Ohanian, DO^1*, Martha L. Arellano, MD², Moshe Y. Levy, MD³, Kristen O'Dwyer, MD⁴, Hani Babiker, MD^5*, Daruka Mahadevan, MD, PhD⁶, Hongying Zhang, MD, PhD^7*, Nasrin Rastgoo, PhD^7*, Yuying Jin, PhD^7*, Jotin Marango, MD., Ph.D.^7*, Stephen B Howell, MD⁸, William G Rice, PhD⁷ and Rafael Bejar, MD, PhD^7,8

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
³Baylor University Medical Center, Dallas, TX
⁴University of Rochester Medical Center, Rochester, NY
⁵Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ
⁶UTH Health San Antonio, MD Anderson Cancer Center, San Antonio, TX
⁷Aptose Biosciences, Inc., San Diego, CA
⁸Moores Cancer Center, University of California San Diego Health, La Jolla, CA

Gary J. Schiller, MD¹, Laura Finn, MD², Gail J. Roboz, MD³, Johnnie J. Orozco, MD, PhD⁴, Tiffany Lin^5*, Mary M Chen, MD⁶ and Mohamed M. Hegazi, MD^7*

¹David Geffen School of Medicine at UCLA, Los Angeles, CA
²Ochsner Medical Center, New Orleans, LA
³Division of Hematology Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Actinium Pharmaceuticals, Inc., New York, NY
⁶Actinium Pharmaceuticals, Inc, New York, MD
⁷James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY

Linjie Tian^1*, Ana Paucarmayta^1*, Rustin Lovewell^1*, Karla Maloveste^1*, Junshik Hong, MD^2,3, Carly Hedgepath^2*, Kwang Woon Kim^2*, Ron Copeland^1*, Thomas O’Neill^1*, Shashank Patel^1*, Linda N. Liu, PhD^1*, Han Myint, MD, FRCPath, FRCP¹, Solomon Langermann, PhD^1*, Dallas B Flies^1* and Tae Kon Kim, MD²

¹NextCure, Inc., Beltsville, MD
²Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
³Department of Internal Medicine, Seoul national university hospital, Seoul, Korea, Republic of (South)

Sameem Abedin, MD¹, Guru Subramanian Guru Murthy, MD^1*, Mehdi Hamadani, MD², Laura C. Michaelis, MD¹, Lyndsey Runaas, MD^1*, Karen Carlson, MD, Ph.D.^1* and Ehab L. Atallah, MD³

¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Justin M Watts, MD^1,2, Tara L. Lin, MD^3,4, Alice S. Mims, MD^5,6, Prapti Patel, MD⁷, Paul J Shami, MD^8,9, Elizabeth H. Cull, MD¹⁰, Christopher R. Cogle, MD¹¹, Cynthia Lee, PhD^12* and Fatih Uckun, MD, PhD¹²

¹Sylvester Comprehensive Cancer Center, Miami, FL
²University of Miami Health System, Miami, FL
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Kansas City, KS
⁴University of Kansas Medical Center, Kansas City, KS
⁵Arthur G. James Cancer Center Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁶Ohio State University Wexner Medical Center, Columbus, OH
⁷Division of Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁸Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁰GHS Cancer Institute, Greenville, SC
¹¹Department of Medicine, University of Florida, Gainesville, FL
¹²Aptevo Therapeutics, Seattle

Tara L. Lin, MD¹, Justin M Watts, MD^2,3, Alice S. Mims, MD^4,5, Prapti Patel, MD⁶, Paul J Shami, MD^7,8, Elizabeth H. Cull, MD^9,10, Christopher R. Cogle, MD¹¹, Cynthia Lee, PhD^12* and Fatih Uckun, MD, PhD¹²

¹University of Kansas, Westwood, KS
²Sylvester Comprehensive Cancer Center, Miami, FL
³University of Miami Health System, Miami, FL
⁴The Ohio State University, Columbus, OH
⁵Arthur G. James Cancer Center Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁶Division of Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁸Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁹GHS Cancer Institute, Greenville, SC
¹⁰Cancer Institute, Prisma Health, Piedmont, SC
¹¹Department of Medicine, University of Florida, Gainesville, FL
¹²Aptevo Therapeutics, Seattle

Eytan M. Stein, MD¹, Jörg Chromik, MD^2*, Cecilia Carpio, MD^3*, Rogier Mous, MD, PhD^4*, Jean-Jacques Kiladjian, MD, PhD⁵, Gheath Alatrash, DO, PhD⁶, Antonio Curti, MD, PhD⁷, Charles Craddock, FRCP, FRCPath⁸, Christoph Schmid, MD^9*, Robert Zeiser, MD¹⁰, Lamis K. Eldjerou, MD¹¹, Hans-Jochen Jochen Weber, PhD^12*, Claire Fabre, MD, PhD¹³, Jeffrey Scott, PhD^11* and Daniel J. DeAngelo, MD, PhD¹⁴

¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medical Oncology, Goethe Universitat Frankfurt, Frankfurt am Main, Germany
³Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁴Universitair Medisch Centrum Utrecht, Academic Medical Center, Utrecht, NH, Netherlands
⁵Hôpital Saint-Louis; Université de Paris, INSERM, Paris, France
⁶Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁷IRCCS Azienda ospedaliero-universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
⁸Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom
⁹Department of Hematology and Oncology / Stem Cell Transplantation, Augsburg University Hospital and Medical Faculty, Augsburg, Germany
¹⁰Department of Medicine I Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
¹¹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹²Novartis Pharma AG, Basel, Switzerland
¹³Novartis Pharmaceuticals Corporation, Basel, Switzerland
¹⁴Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA

Camille Abboud Sr., MD^1,2, Gautam Borthakur, MD³, Scott R. Solomon, MD⁴, Howard A. Burris Sr., MD⁵, Terrence Bradley, MD⁶, JAN Maciej Zaucha Sr.^7*, Ewa Lech-Marańda, MD, PhD^8*, Krzysztof Brzozka, PhD^9*, Tomasz Rzymski, PhD^9*, Peter Littlewood, BSc^10*, Elie Mouhayar, MD^11*, Setareh Shamsili, MD, PhD^9* and Noemi Angelosanto, MD⁹

¹Division of Oncology, Washington University In Saint Louis;, Saint Louis, MO
²Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA
⁵Sarah Cannon Research Institute, Nashville, TN
⁶University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
⁷Medical University of Gdansk, Gdansk, Poland
⁸Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁹Ryvu Therapeutics, Cracow, Poland
¹⁰Ryvu Therapeutics, Krakow, Poland
¹¹MDACC, Houston, TX

Sai Prasad Desikan, MD^1*, Hagop Kantarjian, MD², Courtney D. DiNardo, MD, MSCE², Gautam Borthakur, MD³, Naval Daver, MD⁴, Naveen Pemmaraju, MD², Yesid Alvarado, MD², Jan A. Burger, MD, PhD⁵, Debra Bull Linderman, RN^4*, Sherry A. Pierce, BSN, BA^2*, Farhad Ravandi, MB Bs⁶, Guillermo Garcia-Manero, MD² and Tapan M. Kadia, MD⁷

¹Leukemia, MD Anderson, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³MD Anderson Cancer Center, The University of Texas, Houston, TX
⁴MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
⁷Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX

Alice S. Mims, MD¹, Melhem Solh, MD², Jennifer N. Saultz, DO³, Uma Borate, MD⁴, Naveen Pemmaraju, MD⁵, Gautam Borthakur, MD⁵, Gail J. Roboz, MD⁶, Ben Powell, PhD^7*, Bernice Matusow^7*, Jason Halladay, PhD^7*, Shireen Vali, PhD^7*, Chelsea L. Hope, PhD^7*, Madan G. Kundu, PhD^8*, Ching Hsu, PhD^8*, Paul Watkins^7*, Chao Zhang, PhD^7*, Jackie M. Walling, PhD, MD⁷, Athanasios C. Tsiatis, MD⁷ and Amy E. DeZern, MD⁹

¹The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Northside Hospital Cancer Institute, Atlanta, GA
³Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁴The James Cancer Center, The Ohio State University, Columbus, OH
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Division of Hematology/Oncology, Department of Medicine, Weill Medical College of Cornell university, New York, NY
⁷Plexxikon Inc., Berkeley, CA
⁸Daiichi Sankyo, Basking Ridge, NJ
⁹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Naveen Pemmaraju, MD¹, Kapil N. Bhalla, MD¹, Naval Daver, MD², Nathaniel R Wilson, MD^3*, Warren C. Fiskus, BSc, PhD⁴, Farhad Ravandi, MB Bs⁵, Guillermo Garcia-Manero, MD¹, Tapan M. Kadia, MD⁶, Courtney D. DiNardo, MD, MSCE¹, Elias J. Jabbour⁷, Jan A. Burger, MD, PhD¹, Nicholas Short, MD⁵, Yesid Alvarado, MD¹, Nitin Jain, MD⁸, Lucia Masarova, MD^4*, Srdan Verstovsek, MD, PhD⁶, Ghayas C. Issa, MD¹, Wei Qiao, PhD^9*, Joseph D. Khoury¹⁰, Sherry A. Pierce, BSN, BA^1*, Darla Miller^1*, Marina Konopleva, MD, PhD¹, Hagop Kantarjian, MD¹ and Gautam Borthakur, MD¹¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²MD Anderson Cancer Center, Houston, TX
³Internal Medicine, The University of Texas Health Sciences Center at Houston, Houston, TX
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
⁶Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁸Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁹Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹MD Anderson Cancer Center, The University of Texas, Houston, TX

Andrius Zucenka^1,2*, Vilmantė Vaitekėnaitė, MD^1*, Kazimieras Maneikis, MD^1*, Regina Pileckytė, MD, PhD^1,2*, Igoris Trociukas, MD^1*, Valdas Pečeliūnas, MD, PhD^1,2* and Laimonas Griškevičius, MD, PhD^1,2*

¹Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
²Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania

Marina Konopleva, MD, PhD¹, Danielle M. Brander, MD², Krish Patel^3*, Catherine S. Diefenbach, MD⁴, Yesid Alvarado, MD⁵, Olga Frankfurt, MD^6*, Monzr M. Al Malki, MD⁷, Alexey V. Danilov, MD, PhD^8,9, Sameem Abedin, MD¹⁰, Kebede H. Begna, MD¹¹, Avyakta Kallam, MD¹², Richard G. Ghalie, MD, MBA¹³ and Matthew S. Davids, MD¹⁴

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Duke Cancer Institute, Duke University Medical Center, Durham, NC
³Swedish Cancer Institute, Seattle, WA
⁴New York University, New York, NY
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Northwestern University, Chicago, IL
⁷Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁸City of Hope Toni Stephenson Lymphoma Center, Duarte, CA
⁹City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁰Blood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹¹Divison of Hematology, Mayo Clinic, Rochester, MN
¹²Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
¹³MEI Pharma, San Diego, CA
¹⁴Dana-Farber Cancer Institute, Boston, MA

Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath^1,2, Naval Daver, MD³, Mark Chao, MD, PhD⁴, Guan Xing, PhD^4*, Camille Renard, MSc^4*, Giri Ramsingh, MD^4*, Andrew H. Wei, MD, PhD⁵ and David A. Sallman, MD⁶

¹MRC Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
²MRC Molecular Haematology Unit and Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals, Oxford, United Kingdom
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Gilead Sciences, Inc., Foster City, CA
⁵Department of Haematology, Alfred Hospital and Monash University, Melbourne, Australia
⁶Moffitt Cancer Center, Tampa, FL

Sung-Soo Yoon, MD¹, Dong-Yeop Shin, MD, PhD^2*, Je-Hwan Lee, MD, PhD³, Jun Ho Jang, MD, PhD⁴, June-Won Cheong, MD, PhD⁵, Ho-Jin Shin, MD, PhD^6*, Jeong-Ok Lee, MD Ph.D.⁷, Yunsuk Choi, MD., Ph.D.^8*, Anish Puliyayil, MD. DM. FRACP.^9*, Joseph Clarey, MBBS FRACP FRCPA^10*, Jeejin Im^11*, Ky-Youb Nam, PhD^11*, Kyu-Tae Kim, PhD^11*, June Han^11*, Jeong-Hyeok Yoon, PhD.^11*, Bao Nguyen^12*, Li Li, MD., PhD.^12* and Donald Small, MD., PhD.¹²

¹Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
²Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
³Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁵Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, KOR
⁶Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
⁷Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
⁸Department of Hematology and Oncology, Ulsan University Hospital, Ulsan, Korea, Republic of (South)
⁹Border Medical Oncology and Haematology, Albury-Wodonga Cancer Centre, Albury, Australia
¹⁰ICON caner centre, North Mackay, Australia
¹¹Pharos iBio Co., Ltd., Anyang, Korea, Republic of (South)
¹²Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

Naval Daver, MD¹, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath², Mark Chao, MD, PhD³, Guan Xing, PhD^3*, Camille Renard, MSc^3*, Giri Ramsingh, MD^3*, David A. Sallman, MD⁴ and Andrew H. Wei, MD, PhD⁵

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Weatherall Institute of Molecular Medicine, Weatherall Inst. of Molecular Medicine, Oxford, United Kingdom
³Gilead Sciences, Inc., Foster City, CA
⁴Moffitt Cancer Center, Tampa, FL
⁵Department of Haematology, Alfred Hospital and Monash University, Melbourne, Australia